Casi Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.15

+0.01 (+3.57%)

As of May 23, 2:26 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +27,575.9% upside

Low Target $29.11

Average Target $40.13

High Target $50.28

Current Price $0.15

Current
$0.15

Target
$40.13

$29.11 $40.13 avg $50.28

Scenario Analysis

Bear Case

$29.11

19,975.9%

Low target

Base Case

$40.13

+27,575.9%

Avg target

Bull Case

$50.28

+34,575.9%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$3.09

-95.3% from high

52-Week Low

$0.05

+190.0% from low

Target vs 52W High

$40.13

+1,198.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%